AI-powered Computational Pathology for Immunotherapy
Ellogon AI has raised $353K in total funding. The most recent round was Convertible Note. The last funding was announced in August 2021.
Ellogon AI's investors include Innovatiefonds Noord-Holland.
Ellogon AI is headquartered in Amsterdam, The Netherlands.
AI-powered Computational Pathology for Immunotherapy
Ellogon AI is at the Convertible Note stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ellogon AI — Funding & Investors." VCBacked, August 24, 2021, https://www.vcbacked.co/company/ellogon-ai. Accessed August 13, 2026.
VCBacked. (2021). Ellogon AI — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/ellogon-ai
{{cite web |title=Ellogon AI — Funding & Investors |url=https://www.vcbacked.co/company/ellogon-ai |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated